These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 11266245)

  • 1. The modern alchemy of clinical pathology: turning the output of microbiology laboratory operations into gold.
    Kanjilal S
    J Clin Microbiol; 2024 May; 62(5):e0170922. PubMed ID: 38506516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Need for Dedicated Microbiology Leadership in the Clinical Microbiology Laboratory.
    Samuel LP; Hansen GT; Kraft CS; Pritt BS;
    J Clin Microbiol; 2021 Jul; 59(8):e0154919. PubMed ID: 33597258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnitude of Extended-Spectrum Beta-Lactamase-Producing Gram-Negative and Beta-Lactamase-Producing Gram-Positive Pathogens Isolated from Patients in Dar es Salaam, Tanzania: A Cross-Sectional Study.
    Mloka D; Sangeda RZ; Mwambete KD; Kamuhabwa AR
    Cureus; 2022 Apr; 14(4):e24451. PubMed ID: 35651392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro vancomycin susceptibility amongst methicillin resistant Staphylococcus aureus.
    Chaudhari CN; Tandel K; Grover N; Bhatt P; Sahni AK; Sen S; Prahraj AK
    Med J Armed Forces India; 2014 Jul; 70(3):215-9. PubMed ID: 25378772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae.
    Anderson DJ; Engemann JJ; Harrell LJ; Carmeli Y; Reller LB; Kaye KS
    Antimicrob Agents Chemother; 2006 May; 50(5):1715-20. PubMed ID: 16641440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-spectrum beta-lactamases: a clinical update.
    Paterson DL; Bonomo RA
    Clin Microbiol Rev; 2005 Oct; 18(4):657-86. PubMed ID: 16223952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kirby-Bauer disc approximation to detect inducible third-generation cephalosporin resistance in Enterobacteriaceae.
    Qin X; Weissman SJ; Chesnut MF; Zhang B; Shen L
    Ann Clin Microbiol Antimicrob; 2004 Jul; 3():13. PubMed ID: 15256000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the NCCLS extended-spectrum beta-lactamase confirmation methods for Escherichia coli with isolates collected during Project ICARE.
    Tenover FC; Raney PM; Williams PP; Rasheed JK; Biddle JW; Oliver A; Fridkin SK; Jevitt L; McGowan JE;
    J Clin Microbiol; 2003 Jul; 41(7):3142-6. PubMed ID: 12843054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of extended-spectrum and AmpC beta-lactamases in bloodstream isolates of Klebsiella pneumoniae: isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC beta-lactamases.
    Coudron PE; Hanson ND; Climo MW
    J Clin Microbiol; 2003 Feb; 41(2):772-7. PubMed ID: 12574281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of decreased susceptibility to cefpodoxime in Escherichia coli.
    Oliver A; Weigel LM; Rasheed JK; McGowan JE; Raney P; Tenover FC
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3829-36. PubMed ID: 12435684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin resistance in staphylococci.
    Srinivasan A; Dick JD; Perl TM
    Clin Microbiol Rev; 2002 Jul; 15(3):430-8. PubMed ID: 12097250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory reporting of Staphylococcus aureus with reduced susceptibility to vancomycin in United States Department of Veterans Affairs facilities.
    Kralovic SM; Danko LH; Roselle GA
    Emerg Infect Dis; 2002 Apr; 8(4):402-7. PubMed ID: 11971775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.
    Paterson DL; Ko WC; Von Gottberg A; Casellas JM; Mulazimoglu L; Klugman KP; Bonomo RA; Rice LB; McCormack JG; Yu VL
    J Clin Microbiol; 2001 Jun; 39(6):2206-12. PubMed ID: 11376058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus.
    Tenover FC; Biddle JW; Lancaster MV
    Emerg Infect Dis; 2001; 7(2):327-32. PubMed ID: 11294734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory capacity to detect antimicrobial resistance, 1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Jan; 48(51-52):1167-71. PubMed ID: 11266245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility testing: special needs for fastidious organisms and difficult-to-detect resistance mechanisms.
    Jorgensen JH; Ferraro MJ
    Clin Infect Dis; 2000 May; 30(5):799-808. PubMed ID: 10816150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of laboratory-generated vancomycin intermediate resistant Staphylococcus aureus strains.
    Bhateja P; Purnapatre K; Dube S; Fatma T; Rattan A
    Int J Antimicrob Agents; 2006 Mar; 27(3):201-11. PubMed ID: 16417988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended spectrum beta lactamase--mediated resistance among isolates of family Enterobacteriaceae.
    Deep ; Arora U
    Indian J Pathol Microbiol; 2007 Apr; 50(2):458-61. PubMed ID: 17883109
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.